project id: TCGA-PRAD; case submitter id: TCGA-KC-A4BR; source center: 23; state: released; a260 a280 ratio: 1.86; age at index: 75; days to birth: -27741; ethnicity: not reported; gender: male; race: white; vital status: Alive; year of birth: 1934; age at diagnosis: 27741; ajcc clinical m: M0; ajcc clinical t: T2; ajcc pathologic n: N1; ajcc pathologic t: T3b; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 1349.0; icd 10 code: C61; last known disease status: not reported; morphology: 8140/3; primary diagnosis: Adenocarcinoma, NOS; primary gleason grade: Pattern 4; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; secondary gleason grade: Pattern 5; site of resection or biopsy: Prostate gland; synchronous malignancy: No; tissue or organ of origin: Prostate gland; tumor grade: Not Reported; year of diagnosis: 2009; treatment or therapy: yes; alcohol history: Not Reported; is ffpe: false; weight: 30.0; days to collection: 1161; initial weight: 600.0; sample id: b89ac223-9bcc-4ae8-ba4d-6851e291e452; sample submitter id: TCGA-KC-A4BR-01A; portion id: 4ca759aa-2fa7-4fa1-a3af-13b376c70869; portion submitter id: TCGA-KC-A4BR-01A-32; slide id: 9a3cc218-8ea4-4efe-9e37-12fad174fd0c; slide submitter id: TCGA-KC-A4BR-01A-03-TSC; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 10.0; percent stromal cells: 50.0; percent tumor cells: 40.0; percent tumor nuclei: 60.0; section location: TOP;